SCHEMBL7203937

SCHEMBL7203937

CC(C)(C)OC(=O)N1CCC(O)(c2cnc3ccccc3c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.46
CKS1B P61024 2/20 0.44
SKP1 P63208 2/20 0.44
SKP2 Q13309 2/20 0.44
TACR1 P25103 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
TSHR P16473 2/20 0.42
ALOX15 P16050 1/20 0.42
ATM Q13315 1/20 0.42
SYK P43405 1/20 0.42
GBA1 P04062 1/20 0.41
MMP2 P08253 1/20 0.41
MMP13 P45452 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
BACE1 P56817 1/20 0.41
CCR5 P51681 1/20 0.41
FASN P49327 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8138956 0.82 FASN (0.46) FASNMEN1KMT2A
SCHEMBL240381 0.79 TSHR (0.57) TACR1OPRD1OPRK1TSHRALOX15
SCHEMBL2152225 0.79 CYP11B2 (0.45) CYP11B2CKS1BSKP1SKP2TACR1
SCHEMBL2152449 0.79 ACHE (0.46) CYP11B2CKS1BSKP1SKP2TACR1
SCHEMBL2152319 0.78 CYP11B2 (0.45) CYP11B2CKS1BSKP1SKP2TACR1
SCHEMBL4054998 0.78 AKR1C3 (0.61) CKS1BSKP1SKP2GBA1GPR119
SCHEMBL31254486 0.78 AKR1C3 (0.61) CKS1BSKP1SKP2GBA1GPR119
SCHEMBL6619420 0.78 BACE1 (0.49) CYP11B2CKS1BSKP1SKP2OPRD1
SCHEMBL9326007 0.78 HTR3A (0.54) OPRD1OPRK1FASN
SCHEMBL2153160 0.78 BACE1 (0.44) CYP11B2TACR1OPRD1OPRK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030004207-A1 USE OF COMPOUNDS WHICH ACTIVATE A 5-HT RECEPTOR TO TREAT URINARY INCONTINENCE SYNAPTIC PHARMACEUTICALS CORPORATION 2003-01-02 US disclosed
CN-1315830-A Method for treating anxiety disorders LILLY CO ELI (US) 2001-10-03 CN disclosed
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed